Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Acadia Healthcare Company, Inc. has 90.87M shares outstanding.

As of June 30, 2026, Acadia Healthcare Company, Inc. maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 117.04, indicating elevated leverage, while an interest coverage ratio of -4.96 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. posted a negative return on equity (ROE) of -44.54, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -19.00, reflecting losses generated across the asset base. The company generates approximately 2.34M in revenue per employee across its workforce of 25,125.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.01 indicates how many times Acadia Healthcare Company, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. recorded 450.03M in income tax expense. The company reported a pretax loss of -19.16B and -19.68B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 31, 2026, Acadia Healthcare Company, Inc.'s stock has declined approximately 18.89% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. generated 58.84B in revenue and converted that into -19.68B in net income, yielding earnings per share of -215.90. EBITDA reached -13.09B, while operating income came in at 5.92B.

As of June 30, 2026, Acadia Healthcare Company, Inc. holds 2.99B in cash and equivalents against 44.82B in total debt, resulting in a net debt position of 39.19B. Total book value stands at 34.58B, with working capital of 5.38B providing operational flexibility.

Acadia Healthcare Company, Inc. produced 3.68B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Acadia Healthcare Company, Inc. posted a gross margin of 96.41, reflecting its pricing power and cost economics. The operating margin of 10.06 and net profit margin of -33.44 provide insight into operational efficiency.

Acadia Healthcare Company, Inc.'s most recent stock split took place on November 1, 2011 with a 4:1 split ratio.